159837 生物科技
已收盘 04-03 15:00:00
资讯
新帖
简况
圣湘生物（688289）披露关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案，4月3日股价下跌2.63%
证券之星 · 04-03 17:40
圣湘生物（688289）披露关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案，4月3日股价下跌2.63%
诚益通：公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程（ZTAZ-1标）项目中标通知书
证券之星 · 04-01
诚益通：公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程（ZTAZ-1标）项目中标通知书
美股异动丨生物科技公司Centessa暴涨近46%，获礼来以高达78亿美元的价格收购
格隆汇 · 03-31
美股异动丨生物科技公司Centessa暴涨近46%，获礼来以高达78亿美元的价格收购
每周股票复盘：安琪酵母（600298）投建白洋生物科技园二期
证券之星 · 03-22
每周股票复盘：安琪酵母（600298）投建白洋生物科技园二期
艾科联生物科技完成数千万美元融资 |【经纬低调新闻】
经纬创投 · 03-19
艾科联生物科技完成数千万美元融资 |【经纬低调新闻】
公告精选︱安琪酵母：宜昌高新区公司拟7.97亿元实施白洋生物科技园项目二期；顺灏股份：轨道辰光的“天数天算”业务可能在未来5年内才有明确的商业价值
格隆汇 · 03-18
公告精选︱安琪酵母：宜昌高新区公司拟7.97亿元实施白洋生物科技园项目二期；顺灏股份：轨道辰光的“天数天算”业务可能在未来5年内才有明确的商业价值
安琪酵母最新公告：拟投建白洋生物科技园项目二期
证券之星 · 03-18
安琪酵母最新公告：拟投建白洋生物科技园项目二期
步长制药（603858）披露控股子公司拟转让湖南众测生物科技60%股权公告，3月17日股价上涨0.12%
证券之星 · 03-17
步长制药（603858）披露控股子公司拟转让湖南众测生物科技60%股权公告，3月17日股价上涨0.12%
港股异动 | 正大企业国际(03839)午后涨近14% 拟更名为“正大生物”生物科技业务贡献全部收入
智通财经 · 03-17
港股异动 | 正大企业国际(03839)午后涨近14% 拟更名为“正大生物”生物科技业务贡献全部收入
华润医药(03320)：华润医药投资拟挂牌出售天麦生物科技约5.88%股权
智通财经 · 03-16
华润医药(03320)：华润医药投资拟挂牌出售天麦生物科技约5.88%股权
新股消息 | 传生物科技初创公司Earendil Labs拟赴港IPO 融资规模或高达5亿美元
智通财经 · 03-13
新股消息 | 传生物科技初创公司Earendil Labs拟赴港IPO 融资规模或高达5亿美元
香港交易所罗博仁：今年香港生物科技行业增长动力依然稳固
智通财经 · 03-06
香港交易所罗博仁：今年香港生物科技行业增长动力依然稳固
2026年中国生物科技授权交易将迎爆发式增长，有望创历史新高
环球市场播报 · 02-13
2026年中国生物科技授权交易将迎爆发式增长，有望创历史新高
四方光电：2026年1月，公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权
证券日报 · 02-12
四方光电：2026年1月，公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权
百龙创园(605016.SH)拟设立百龙创园(南京)生物科技有限公司
智通财经 · 02-11
百龙创园(605016.SH)拟设立百龙创园(南京)生物科技有限公司
华润医药(03320)潜在出售天麦生物科技约17.87 %股权
智通财经 · 02-09
华润医药(03320)潜在出售天麦生物科技约17.87 %股权
山西山阴生物科技公司爆炸已致8人遇难，涉事企业法人代表已被控制
新京报网 · 02-08
山西山阴生物科技公司爆炸已致8人遇难，涉事企业法人代表已被控制
山东新华制药股份(00719)终止收购挪亚圣诺(太仓)生物科技有限公司股权
智通财经 · 02-06
山东新华制药股份(00719)终止收购挪亚圣诺(太仓)生物科技有限公司股权
新华医疗最新公告：终止收购武汉中帜生物科技股份有限公司36.19%股权
证券之星 · 02-06
新华医疗最新公告：终止收购武汉中帜生物科技股份有限公司36.19%股权
爱普股份(603020.SH)签订关于挪亚圣诺(太仓)生物科技有限公司股权收购意向协议
智通财经 · 02-06
爱普股份(603020.SH)签订关于挪亚圣诺(太仓)生物科技有限公司股权收购意向协议
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159837","market":"SZ","secType":"STK","nameCN":"生物科技","latestPrice":0.487,"timestamp":1775199783000,"preClose":0.499,"halted":0,"volume":85734934,"delay":0,"changeRate":-0.024,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.012,"latestTime":"04-03 15:00:00","open":0.494,"high":0.495,"low":0.485,"amount":41918000,"amplitude":0.02,"askPrice":0.487,"askSize":10709,"bidPrice":0.486,"bidSize":2625,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":0.499,"symbolType":"fund","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":0.549,"lowLimit":0.449,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.21613,"marketValue":0,"turnoverRate":0,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-08。","floatMarketCap":0},"requestUrl":"/m/hq/s/159837","defaultTab":"news","newsList":[{"id":"2624591736","title":"圣湘生物（688289）披露关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案，4月3日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624591736?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:40","pubTimestamp":1775209229,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，圣湘生物报收于17.76元，较前一交易日下跌2.63%，最新总市值为102.9亿元。该股当日开盘18.19元，最高18.22元，最低17.75元，成交额达7054.79万元，换手率为0.68%。公告显示，公司于2026年3月31日召开2026年第一次临时股东会，审议通过《关于与关联方共同投资华斯无微生物科技（深圳）有限公司的议案》。关联股东未出席本次会议。湖南启元律师事务所对本次会议进行了见证并出具法律意见书，认为会议决议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","HBImain","159837","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624560898","title":"诚益通：公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程（ZTAZ-1标）项目中标通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2624560898","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624560898?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:00","pubTimestamp":1775026842,"startTime":"0","endTime":"0","summary":"证券之星消息，诚益通03月31日在投资者关系平台上答复投资者关心的问题。诚益通回复：尊敬的投资者您好，公司3月份收到黑龙江伊品生物科技有限公司45万吨氨基酸及配套加工项目淀粉、制糖车间安装工程项目中标通知书，中标金额为1775.57万元，目前暂未签订合同，签订合同日期以实际签约时间为准。该项目金额未达到重大合同披露标准。如达到信息披露标准，公司将按法律法规要求进行披露，请您关注公司公告。再次感谢您的建议和支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100021937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300430","159837","BK0225","HBImain","BK0130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623071538","title":"美股异动丨生物科技公司Centessa暴涨近46%，获礼来以高达78亿美元的价格收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2623071538","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623071538?lang=zh_cn&edition=full","pubTime":"2026-03-31 23:09","pubTimestamp":1774969770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"044b49fac9463464d2e44ed274e1a9ed","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0471298694.HKD","LU1804176565.USD","LU2471134952.CNY","LU0266013472.USD","LU2023250330.USD","LU0889565916.HKD","LU2361044865.SGD","SGXZ99366536.SGD","LU1989771016.USD","LU0820562030.AUD","LU1023059063.AUD","LU0316494557.USD","LLII","LU0820561818.USD","LU2602419157.SGD","LU2111349929.HKD","BK4533","LU1974910355.USD","LU2168564149.EUR","ELIS","LLYX","LU0079474960.USD","SG9999015952.SGD","LLY","LU2271345857.HKD","IE00B7KXQ091.USD","LU0353189763.USD","159837","LU0058720904.USD","ELIL","LU0353189680.USD","LU1069344957.HKD","LU0786609619.USD","LLYZ","LU0787776722.HKD","HBImain","SG9999013999.USD","XBI","LU2023250504.SGD","LU2361044949.HKD","BK4599","LU0354030511.USD","LU0158827948.USD","BK4534","LU1623119135.USD","LU1280957306.USD","LU0823434583.USD","IE00BJJMRX11.SGD","LU1093756325.SGD","LU2756315664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796084","title":"每周股票复盘：安琪酵母（600298）投建白洋生物科技园二期","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796084","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796084?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:26","pubTimestamp":1774117573,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，安琪酵母报收于40.17元，较上周的42.09元下跌4.56%。本周，安琪酵母3月16日盘中最高价报42.3元。本周关注点公司公告汇总：安琪酵母拟投资79,739万元实施白洋生物科技园项目二期。公司公告汇总安琪酵母股份有限公司于2026年3月18日召开第十届董事会第十一次会议，审议通过多项议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HBImain","LU1064131003.USD","600298","BK0226","BK0185","LU1064130708.USD","LU2580892789.USD","159837","LU2148510915.USD","BK0188","BK0175","LU2580892862.HKD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620733247","title":"艾科联生物科技完成数千万美元融资 |【经纬低调新闻】","url":"https://stock-news.laohu8.com/highlight/detail?id=2620733247","media":"经纬创投","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620733247?lang=zh_cn&edition=full","pubTime":"2026-03-19 12:06","pubTimestamp":1773893160,"startTime":"0","endTime":"0","summary":"综述今日，专注于研发肿瘤与自身免疫性疾病下一代 T 细胞衔接器疗法的生物技术企业艾科联生物科技 宣布，公司已顺利完成超额认购的 6870 万美元融资。艾科联生物科技由方磊博士与朱杰伦先生联合创立。艾科联生物科技首创“中国式 NewCo”模式，整合连续创业家团队、优质管线资产与顶尖资本各核心要素，加速药物研发进程。目前，公司已迅速成长为一家聚焦下一代 TCE 疗法的多平台临床阶段的生物技术企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3ODk5OTEzOA==&mid=2962187047&idx=2&sn=0355725ff34196e2d12bba68f7a9ce9c&chksm=ab6e3f36652f88018e812be9e1f5cf2932a3592d9796294fd50ce1d539e376eb04fae7ba78e5&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK4581","BK4588","BK4585","XBI","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620254652","title":"公告精选︱安琪酵母：宜昌高新区公司拟7.97亿元实施白洋生物科技园项目二期；顺灏股份：轨道辰光的“天数天算”业务可能在未来5年内才有明确的商业价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2620254652","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620254652?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:00","pubTimestamp":1773842448,"startTime":"0","endTime":"0","summary":"沃森生物：拟向腾云新沃定增募资不超过20.03亿元","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4113413","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0226","XBI","BK0185","BK4585","LU2580892789.USD","BK0175","BK4588","600298","002565","LU1064130708.USD","BK0028","HBImain","BK0222","LU2148510915.USD","LU2580892862.HKD","BK4581","159837","LU1064131003.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620323429","title":"安琪酵母最新公告：拟投建白洋生物科技园项目二期","url":"https://stock-news.laohu8.com/highlight/detail?id=2620323429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620323429?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:19","pubTimestamp":1773829195,"startTime":"0","endTime":"0","summary":"安琪酵母(600298.SH)公告称，宜昌高新区公司拟实施白洋生物科技园项目二期，总投资7.97亿元。项目将建设年产12000吨高纯度酵母蛋白及联产产品核心技术攻关项目和年产20,000吨酵母蛋白及联产产品绿色制造项目。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800033248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","LU2148510915.USD","LU2580892789.USD","HBImain","LU1064131003.USD","BK0185","BK0028","LU2580892862.HKD","600298","159837","BK0226","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620473046","title":"步长制药（603858）披露控股子公司拟转让湖南众测生物科技60%股权公告，3月17日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473046","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620473046?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:31","pubTimestamp":1773757874,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，步长制药报收于17.01元，较前一交易日上涨0.12%，最新总市值为179.38亿元。公告显示，公司控股子公司步长（广州）医学诊断技术有限公司拟将其持有的湖南众测生物科技有限公司60.00%股权以1.00元价格转让给杨福太。转让完成后，步长（广州）医学诊断不再直接或间接持有湖南众测及长沙众测生物科技有限公司股权。各方已签署股权转让协议，基准日为2025年12月31日，股权转让价款为1元，乙方应在协议签署后5个工作日内支付。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159837","HBImain","BK0196","BK0239","603858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620433084","title":"港股异动 | 正大企业国际(03839)午后涨近14% 拟更名为“正大生物”生物科技业务贡献全部收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2620433084","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620433084?lang=zh_cn&edition=full","pubTime":"2026-03-17 13:59","pubTimestamp":1773727170,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，正大企业国际(03839)午后涨近14%，截至发稿，涨13.08%，报7.35港元，成交额405.29万港元。消息面上，正大企业国际公布，拟更名为“正大生物控股有限公司”。此次更名计划旨在更精准体现本公司目前的主营业务及未来的战略布局，进一步强化本公司致力成为世界领先的生物科技公司的愿景。据悉，公司目前的收入全部来自生物科技业务(动保兽药及金霉素产品)。值得注意的是，今年1月份，正大企业国际发布盈喜，预期2025年股东应占综合溢利约3200万美元，2024年同期则录得1120万美元。溢利增长主要由于收入的大幅增长，反映了公司成功地实施开发大客户销售关键策略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","HBImain","XBI","03839","VXUS","BK4581","159837","BK1212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619888469","title":"华润医药(03320)：华润医药投资拟挂牌出售天麦生物科技约5.88%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2619888469","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619888469?lang=zh_cn&edition=full","pubTime":"2026-03-16 21:42","pubTimestamp":1773668550,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布，公司全资附属公司华润医药投资有限公司已启动潜在出售华润医药投资所持有合肥天麦生物科技发展有限公司(天麦生物科技)的约5.88%股权，其将通过上海联合产权交易所进行公开挂牌，初步挂牌底价约为人民币5.1亿元。潜在出售事项与华润医药投资及其附属公司出售天麦生物科技的若干股权属独立且互不相关的事项。于本公告日期，华润医药投资及其附属公司持有天麦生物科技约23.75%股权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1570","BK1191","XBI","BK4581","BK4588","BK4585","03320","159837","HBImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619163200","title":"新股消息 | 传生物科技初创公司Earendil Labs拟赴港IPO 融资规模或高达5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619163200","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619163200?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:13","pubTimestamp":1773382386,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体引述知情人士透露，生物科技初创公司Earendil Labs正在考虑在香港上市，正与中金公司和摩根士丹利着手安排股票发行，融资规模可能高达5亿美元。目前，Earendil、中金公司和摩根士丹利均未回应置评请求。合作项目上，Earendil与赛诺菲等企业合作，其中包括今年1月宣布的一项自身免疫及炎症疾病的合作项目。Earendil在2月与在香港上市的药明合联就癌症疗法技术达成协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","HBImain","BK4585","159837","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617500391","title":"香港交易所罗博仁：今年香港生物科技行业增长动力依然稳固","url":"https://stock-news.laohu8.com/highlight/detail?id=2617500391","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617500391?lang=zh_cn&edition=full","pubTime":"2026-03-06 15:16","pubTimestamp":1772781416,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港交易所证券产品发展主管罗博仁表示，生物科技为全球投资市场最备受关注的主题之一。今年香港生物科技行业的增长动力依然稳固，并反映于相关股份及整体板块表现之中。自2018年香港交易所推出上市制度改革以来，生物科技及医疗保健已成为香港市场中最活跃的板块之一。恒生生物科技指数期货于2025年11月在香港交易所推出，旨在扩阔投资者参与生物科技板块的渠道，同时提供有效的对冲工具。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00388","LU0197773160.USD","80388","LU0651946864.USD","HBImain","LU0348816934.USD","LU0251144936.SGD","LU0898667661.SGD","LU0979878070.USD","LU0607220059.USD","LU2039709279.SGD","LU1504937902.USD","LU1282648689.USD","LU0261947096.USD","LU0516423091.SGD","LU0052750758.USD","LU0955648018.USD","LU0630378692.HKD","BK1610","LU0577902298.EUR","LU1981816686.USD","LU0048580855.USD","HKXCY","LU0918141705.HKD","LU2226246903.HKD","BK4588","LU1044876610.USD","LU0577902371.SGD","IE00BZ08YR35.GBP","LU0417516902.SGD","LU0384037296.USD","IE00B3T34201.USD","LU0516423174.USD","159837","LU0955669360.SGD","HEXmain","SG9999004220.SGD","LU0791591158.USD","LU1328277881.USD","SG9999002562.SGD","LU0819121731.USD","LU0210527791.USD","LABU","LU1642822792.SGD","LU1211504680.USD","LU0106959298.USD","LU1226287529.USD","LU1105468828.SGD","LU2449936058.SGD","LU0072913022.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611130059","title":"2026年中国生物科技授权交易将迎爆发式增长，有望创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2611130059","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611130059?lang=zh_cn&edition=full","pubTime":"2026-02-13 17:52","pubTimestamp":1770976320,"startTime":"0","endTime":"0","summary":"全球制药企业在专利到期前纷纷削减成本，正加大力度寻找中国研发的创新候选药物，行业分析师预计，今年相关授权交易规模将飙升至历史新高。 中国大陆是这一浪潮的绝对核心。 “未来 18–24 个月，这类对外授权交易总额有望再翻一番。全球药企正高度聚焦在中国寻找下一代创新药管线，并探索多种交易结构。” 2026 年至今已宣布38 笔对外授权交易；2025 年全年为186 笔。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-13/doc-inhmskfk5919270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LABU","159837","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610692400","title":"四方光电：2026年1月，公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610692400","media":"证券日报 ","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610692400?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:38","pubTimestamp":1770903480,"startTime":"0","endTime":"0","summary":"证券日报网2月12日讯 ，四方光电在接受调研者提问时表示，2026年1月，公司以自有资金受让出资额并增资的方式取得苏州畅合生物科技有限公司57.14%的股权。本次投资是基于公司战略发展规划所作出的审慎决策，旨在拓展公司在生物安全监测领域的业务布局。此次战略整合畅合生物，双方将在产品技术开发、运营生产和销售渠道等方面深度融合，将四方光电的传感器产业领域向更加高端的生物安全检测仪器领域拓展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-12/doc-inhmqmpz6698250.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-12/doc-inhmqmpz6698250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4588","159837","688665","BK4585","BK0214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610780989","title":"百龙创园(605016.SH)拟设立百龙创园(南京)生物科技有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2610780989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610780989?lang=zh_cn&edition=full","pubTime":"2026-02-11 15:40","pubTimestamp":1770795623,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百龙创园(605016.SH)发布公告，公司基于发展战略规划及经营发展需要，以自有资金1000万元，在南京投资设立全资子公司百龙创园(南京)生物科技有限公司(简称“南京百龙”)，公司直接持有南京百龙100%的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","BK4585","159837","LABU","605016","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610321176","title":"华润医药(03320)潜在出售天麦生物科技约17.87 %股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610321176","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610321176?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:47","pubTimestamp":1770637624,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，本公司全资附属公司华润医药投资有限公司(华润医药投资)已启动潜在出售华润医药投资及其附属公司所持有合肥天麦生物科技发展有限公司(天麦生物科技)的约17.87 %股权(潜在出售事项)，其将通过上海联合产权交易所进行公开挂牌，挂牌底价约为人民币14.2亿元。于本公告日期，华润医药投资及其附属公司持有天麦生物科技少于30 %股权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","LABU","BK1570","159837","BK4588","BK4585","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609522115","title":"山西山阴生物科技公司爆炸已致8人遇难，涉事企业法人代表已被控制","url":"https://stock-news.laohu8.com/highlight/detail?id=2609522115","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609522115?lang=zh_cn&edition=full","pubTime":"2026-02-08 10:03","pubTimestamp":1770516180,"startTime":"0","endTime":"0","summary":"据新华社太原2月8日电 记者8日9时30分左右从山西省朔州市山阴县佳鹏生物科技有限公司“2·07”事故现场指挥部了解到，2月7日凌晨在山阴县佳鹏生物科技有限公司发生的爆炸已造成8人遇难。目前，涉事企业法人代表已被控制，朔州市已经成立事故调查组。事发企业位于距离山阴县城40余公里的一处山洼中，记者在事故现场看到，事发地有暗黄色烟雾散出，现场处置工作仍在进行。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-02-08/doc-inhmaism3364455.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-02-08/doc-inhmaism3364455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4588","159837","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609569452","title":"山东新华制药股份(00719)终止收购挪亚圣诺(太仓)生物科技有限公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609569452","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609569452?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:50","pubTimestamp":1770371401,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，有关本公司与挪亚圣诺(欧洲)公司签署《股权收购意向协议》。股权收购意向协议仅系各方经友好协商达成的初步意向，然而，经进一步讨论及磋商后，订约方未能就正式协议的条款及条件达成共识。本公司因此并无就该项目订立正式协议，该项目亦不会进行。故此，本公司已决定终止该等股权收购意向协议。终止《股权收购意向协议》系本公司审慎研究后作出的决定，不会影响本公司现有生产经营活动，也不会对本公司的发展造成不利影响，不存在损害本公司及全体股东，特别是中小股东利益的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","159837","LABU","00719","BK4588","BK1191","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609631135","title":"新华医疗最新公告：终止收购武汉中帜生物科技股份有限公司36.19%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609631135","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609631135?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:36","pubTimestamp":1770366978,"startTime":"0","endTime":"0","summary":"新华医疗(600587.SH)公告称，公司与交易各方友好协商，决定终止收购武汉中帜生物科技股份有限公司36.1913%股权的事项。由于《股份转让协议》约定的交割期限已过，且付款先决条件未达成，公司未支付任何款项，因此不存在违约情形。本次收购的终止不会对公司现有经营业绩及财务状况产生不利影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600027090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600587","BK0188","BK0251","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609884375","title":"爱普股份(603020.SH)签订关于挪亚圣诺(太仓)生物科技有限公司股权收购意向协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2609884375","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609884375?lang=zh_cn&edition=full","pubTime":"2026-02-06 01:34","pubTimestamp":1770312881,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱普股份 发布公告，为完善公司战略布局，推动产业链的补强与延伸，实现公司高质量发展，2026年2月4日，公司与挪亚圣诺欧洲签订了《关于挪亚圣诺(太仓)生物科技有限公司之股权收购意向协议》，爱普股份拟受让挪亚圣诺(太仓)生物科技有限公司100% 股权，其中：首次交易即爱普股份受让目标公司80%股权，第二次交易于业绩承诺期满后启动，爱普股份将受让目标公司剩余股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","603020","LABU","159837","BK0226"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775404143788,"stockEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0451},{"period":"3month","weight":-0.0142},{"period":"6month","weight":-0.1545},{"period":"1year","weight":0.0406},{"period":"ytd","weight":-0.0142}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,159837,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(159837)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(159837)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}